[Bronchoconstrictor effects of beta-adrenergic blockade in asthma: influence of baseline value (author's transl)].
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000420:Albuterol / Q000494:pharmacology; D001249:Asthma / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects*; D003250:Constriction; D004106:Dilatation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects*; D013147:Spirometry
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D000420:Albuterol
Effet bronchoconstricteur d'un bêta-bloquant adrénergique dans l'asthme: influence de la valeur fonctionnelle de départ.